Alzheimer’s disease and related dementias impact more than 6 million families, with 15 million projected to be affected by 2050. Although we’re learning that it is possible to reduce the risk of dementia and slow the rate of cognitive decline, we do not yet have a national effort focused on prevention. Kelly O’Brien from UsAgainstAlzheimer’s and Dr. David Hoffman of Maria College and the National Association of Chronic Disease Directors talk about why we need a national dementia prevention goal, and how public-private partnerships can advance the fight against Alzheimer’s and related dementias.Hosted by: Leanne Clark-Shirley, PhD, Vice President, Programs & Thought Leadership at the American Society on Aging with Peter Kaldes, President & CEO of the American Society on AgingGuests:Kelly O’Brien, Executive Director, Brain Health Partnership, UsAgainstAlzheimer’sDavid Hoffman, DPS, CCE, Associate Dean for Academic Initiatives and Government Affairs, Maria College, additional faculty appointments with Alden March Bioethics Institute at Albany Medical College and University at Albany School of Public Health and Associate at Large Director, National Association of Chronic Disease DirectorsResources:A Shared National Goal to Reduce Dementia Prevalence Call for a National Dementia Prevention GoalDementia prevention, intervention, and care: 2020 report of the Lancet Commission Public members of the advisory council on Alzheimer's research, care and services: 2020 recommendations

Ver todos los episodios